Event
‘Finding Gold in the Shadow’ – The Challenges of Psychedelic Therapy from a Psychotherapeutic Perspective
The benefits of psychedelic therapy have been very well documented over the past number of years, with cutting edge scientific research showing the healing potential of substances like psilocybin.
This presentation by Inwardbound co-founder Rob Coffey will examine some of the challenges of psychedelic therapy from psychotherapeutic perspective.
Some of the issues that will be addressed include:
• Maps of consciousness and finding the right language
• Dealing with transference, countertransference, erotic transference and projection
• Boundaries in the psychedelic space
• The issue of psychic inflation
• Inner child healing
• Finding meaning in challenging experiences
• Spiritual Emergence v Spiritual Emergency
• The role of the therapist?
Case studies will be referred to in order to give a context for the theory”
Related Events
The State and Future of Psychedelic Therapist Training
Keynotes & Talks
While research clearly acknowledges the therapist’s indispensable role before, during, and after psychedelic therapy sessions, the unique process of training to become a psychedelic therapist is a relatively new endeavor, barely studied and larg…
In Conversation with a Recipient of Psychedelic Therapy Integrated with a Contextual Behavioural Therapy Approach for Complex Trauma
Keynotes & Talks
Diana sought support in preparing and integrating her own psychedelic healing. She now volunteers to speak out about the benefits of psilocybin truffles followed by a trauma-focused integration therapy.
In preparation, we considered Acceptan…
Somatics & Psychedelics: How to use Body Awareness to Heal Trauma and Integrate and Unfold Intense Experiences
Keynotes & Talks
This presentation will introduce the great potential that many of the somatic practices carry and how they could be implemented in conjunction with the psychedelic experience.
Somatics is a field within bodywork and movement studies which e…
Phase 3 Trial with Psilocybin‐assisted Therapy for Depression ‐ European Consortium
Keynotes & Talks
Psilocybin‐assisted therapy shows clear potential for depression and other indications in recent clinical trials. While there are two FDA Breakthrough designation programmes with psilocybin for depression in the US ﴾Usona Institute and Compass…
Treatment of Severe Borderline Personality Disorder with Ketamine ‐ a Case Report
Keynotes & Talks
Abstract: In treatment‐resistant depression sub‐anesthetic doses of ketamine have proven effective whereas usefulness of ketamine in Borderline Personality Disorder ﴾BPD﴿ is unknown. We present a case report of a 20‐year‐old woman with…
